Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Avoiding certain allergens in personal care products may improve symptoms for some patients with lichen planopilaris or frontal fibrosing alopecia.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Placental growth factor may help treat hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

A 4-year-old girl with a rare lupus condition was successfully treated with oral corticosteroids, leading to full recovery and hair regrowth.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

GLI2 increases follistatin production in human skin cells.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Integrin β1 is crucial for liver structure and function, preventing fibrosis.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

The first Japanese case of a genetic hair disorder caused by specific mutations in the LIPH gene was identified.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Low-level laser therapy, now called photobiomodulation, is recognized for its broad medical applications and scientific backing.

Different sPLA2 enzymes have unique roles in phospholipid metabolism and biological processes.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Lichen planopilaris in men often affects the scalp, eyebrows, arms, legs, and beard, with many having family members with hair loss.

Foxp1 helps control hair stem cell growth and response to stress during hair growth cycles.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Platelet-rich fibrin matrix improves tissue regeneration better than platelet-rich plasma.